Health Care: Drugs

Gilead Sciences Inc (GILD: NASDAQ)

$104.83 n/a | n/a%
01/30/15 - 04:00 PM ET
Company Cash Flow
Dec 2013 Dec 2012 Dec 2011 Dec 2010
Cash Flow From Operating Activities
Net Income (Loss) 3.06B 2.57B 2.79B 2.89B
Operating Gains/Losses 0.00 0.00 0.00 0.00
Extraordinary Gains / Losses 0.00 0.00 0.00 0.00
(Increase) Decrease In Receivables -315.30M 197.99M -375.74M -348.88M
(Increase) Decrease in Inventories -343.14M -349.92M -200.79M -161.19M
(Increase) Decrease In Other Current Assets 0.00 0.00 0.00 0.00
(Decrease) Increase In Payables -97.67M 117.48M 428.94M -4.45M
(Decrease) Increase In Other Current Liabilities 341.65M 317.59M 411.36M -65.67M
(Increase) Decrease In Other Working Capital 22.14M 23.24M -29.48M -29.73M
Other Non-Cash Items 363.86M 205.24M 263.32M 346.92M
Net Cash From Continuing Operations 3.10B 3.19B 3.64B 2.83B
Net Cash From Discontinued Operations 0.00 0.00 0.00 0.00
Cash Provided By Investing Activities
Net Cash From Total Operating Activities 3.10B 3.19B 3.64B 2.83B
Sale of Property, Plant & Equipment 0.00 0.00 0.00 0.00
Cash Used for Investing Activities
Sale of Short-Term Investments 0.00 0.00 9.44B 3.72B
Purchases of Property, Plant & Equipment -190.78M -397.05M -131.90M -61.88M
Acquisitions -378.64M -10.75B -588.61M -91.00M
Purchases of Short-Term Investments -256.70M -1.24B -5.13B -5.50B
Other Cash from Investing Activities 0.00 0.00 0.00 0.00
Cash Provided by Financing Activities
Net Cash From Investing Activities -254.36M -11.85B 3.59B -1.94B
Issuance of Debt 2.77B 2.36B 4.66B 2.96B
Cash Used for Financing Activities
Issuance of Capital Stock 313.08M 466.28M 211.74M 376.65M
Repayment of Long-Term Debt -4.44B -1.84B -651.55M -868.41M
Repurchase of Capital Stock -582.36M -667.04M -2.38B -4.02B
Payment of Cash Dividends 0.00 0.00 0.00 0.00
Other Financing Charges, Net -609.17M 244.84M -74.19M 213.14M
Net Cash From Financing Activities -2.54B 563.35M 1.76B -1.34B
Effect of Exchange Rate Changes 2.42M 7.91M -16.53M 77.47M
Net Change in Cash & Cash Equivalents 309.11M -8.08B 8.98B -365.08M

Portfolios with GILD

Latest GILD Headlines from TheStreet

More Financial News for GILD

Press Releases for GILD

See All Press Releases

Partner Headlines for GILD

brokerage partners
connect with Stockpickr
Fan us on FaceBook
Follow us on Twitter